Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy and Safety of Optive Eye Drops in Dry Eye
NCT00243711Phase 3Completed
- Sponsor
- Allergan
- Start
- Sep 2005
- Primary completion
- Apr 2006
- Modality
- Polymer-based Nanoparticles, Implantable Devices, Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of sodium carboxymethylcellulose and glycerol in dry eye syndrome (DED) (2 arms), sponsored by Allergan. Primary endpoint: Dry Eye Symptoms. Started Sep 2005; status: completed.
02
Drugs
sodium carboxymethylcelluloseglycerol
03
Conditions
dry eye syndrome (DED)
Beyond the preview
Go deeper on NCT00243711.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00243711.